« Back
Home /
Atranorin

Atranorin

Item no.	HY-N2907-1mg
Manufacturer	MedChem Express
CASRN	479-20-9
Amount	1 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.41
Formula	C19H18O8
Citations	[1]Studzinska-Sroka E, et al. Atranorin - An Interesting Lichen Secondary Metabolite. Mini Rev Med Chem. 2017;17(17):1633-1645.<br>[2] Zhou R, et al. The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis. Sci Rep. 2017 Aug 15;7(1):8136.
Smiles	O=C(OC1=CC(C)=C(C(OC)=O)C(O)=C1C)C2=C(C)C=C(O)C(C=O)=C2O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Product Description	Atranorin is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1, Wnt, and STAT signaling and suppressing RhoGTPase activity[1][2].
StorageTemperature	-20°C, 3 years (Powder)
Shipping	Blue Ice
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	374.34
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cancer
Solubility	DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target	Endogenous Metabolite; Ras
Pathway	GPCR/G Protein; MAPK/ERK Pathway; Metabolic Enzyme/Protease
Manufacturers Product type	Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Request delivery time